Acceptability of Low Intensity Anticoagulation Therapy after Mechanical Heart Valve Replacement |
Kim, Jong-Woo
(Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Graduate School of Medicine)
Rhie, Sang-Ho (Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Graduate School of Medicine) Kim, Young-Chun (Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Graduate School of Medicine) Yang, Jun-Ho (Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Graduate School of Medicine) Jang, In-Seok (Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Graduate School of Medicine) Choi, Jun-Young (Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Graduate School of Medicine) |
1 | Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107-12 DOI PUBMED |
2 | WHO Expert Committee on Biological Standardization. Requirements for thromboplastins and plasma used to control oral anticoagulation therapy. 33rd Report, Tech Rep Ser 687, Geneva, World Health Organization. 1983;81-105 |
3 | Saour JN, Sieck JO, Mamo LAR, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990;322:428-32 DOI ScienceOn |
4 | Butchart EG, Lewis PA, Bethel JA, Breckenridge IM. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Recommendation for the medtronic hall valve. Circulation 1991;84(5 Suppl):Ⅲ61-9 |
5 | Kim CW. Long-term clinical results of the St. Jude Medical valve in mitral position. Korean J Thorac Cardiovasc Surg 1994;27:664-8 |
6 | Salem DN, Stein PD, AI-Ahmad A, et al. Antithrombotic therapy in valvular heart disease-native and prothetic: in Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):457s-82s DOI PUBMED ScienceOn |
7 | Horstkotte D, Schulte HD, Bircks W, Strauer BE. Low intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994;107:1136-45 PUBMED |
8 | Pengo V, Barbero F, Banzato A, et al. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses. Thromb Haemost 1997;77:839-44 |
9 | Körtke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001;72:44-8 DOI ScienceOn |
10 | Butchart EG. Rationalizing antithrombotic management for patients with prosthetic heart valves. J Heart Valve Dis 1995;4:106-13 |
11 | Soga Y, Okabayshi H, Nishina T, et al. Up to 8-year follow-up of valve replacement with carbomedics valve. Ann Thorac Surg 2002;73:474-9 DOI ScienceOn |
12 | Kim CW, Kim YT. Anticoagulation in patients with the St. Jude Medical prosthesis. Korean J Thorac Cardiovasc Surg 1998;31:684-91 |
13 | ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48: e1-148 DOI ScienceOn |
14 | Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg 2001;72:1523-7 DOI ScienceOn |
15 | Hirsh J, Levien MN. The optimal intensity of oral anticoagulant therapy. JAMA 1987;258:2723 DOI ScienceOn |
16 | Ishibashi Y, Aoki H, Ohba J, Kamikubo Y, Morimoto K, Kumasaka A. PT-INR as a parameter for anticoagulant therapy after valve replacement surgery. Kyobu Geka 1996; 49:906-8 PUBMED |
17 | Langefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med 1993;95:315-28 DOI ScienceOn |
18 | Chikada M, Yagyu K, Kotsuka Y, Furuse A. Anticocgulation therapy after mechanical prosthetic heart valve replacement with special reference to international normalized ratio (INR). Kyobu Geka 1994;47:895-8 PUBMED |
19 | Butchart EG, Payne N, Li HH, et al. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002;123:715-23 DOI ScienceOn |
20 | Langefeld CS, Rosenblatt MW, Goldman L. Bleeding in outpatient treated with warfarin: relation to the prothrombin time and important remediable lesions. Am J Med 1989;87: 153-9 DOI ScienceOn |
21 | 2nd ACCP Conference on Antithrombotic Therapy. Chest 1989;95(Suppl):1s DOI ScienceOn |
22 | Cannegieter SC, Torn M, Rosendaal FR. Oral anticoagulation with mechanical heart valve: how to reduce the risk of thromboembolic and bleeding complications. J Intern Med 1999;245:369-74 DOI ScienceOn |
23 | Hassouna A, Allamt H, Awadt A, Hassadallaht F. Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement. Cardiovasc Surg 2000;8:491-8 |